Farmax India Limited Reports Unaudited Earnings Results for the Second Quarter and Six Months Ended September 30, 2013
For the six months, the company's net sales/income from operations was INR 8.71 million compared to INR 42.11 million a year ago. Loss from operations before other income and exceptional items was INR 6.61 million compared to INR 2.77 million a year ago. Loss from ordinary activities before tax was INR 6.43 million compared to INR 2.69 million a year ago. Net loss was INR 6.43 million compared to INR 2.69 million a year ago. Basic and diluted loss per share before and after extraordinary items was INR 0.16 compared to INR 0.04 a year ago.